SCHEMBL3822706

SCHEMBL3822706

CCOC(=O)c1oc(C2CC2)nc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR2 O43614 1/20 0.53
HSD17B10 Q99714 3/20 0.38
HPGD P15428 3/20 0.38
HTT P42858 2/20 0.38
MAPK1 P28482 1/20 0.38
FBP1 P09467 1/20 0.37
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 4/20 0.37
PLK1 P53350 1/20 0.37
CYP1A2 P05177 1/20 0.37
GAA P10253 2/20 0.36
TSHR P16473 1/20 0.36
RAB9A P51151 3/20 0.36
NPC1 O15118 3/20 0.36
MAPT P10636 2/20 0.36
PDE4D Q08499 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
AHR P35869 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20378349 0.94 HCRTR2 (0.48) HCRTR2HSD17B10HPGDHTTMAPK1
SCHEMBL3530308 0.93 HCRTR2 (0.48) HCRTR2HSD17B10HPGDHTTMAPK1
SCHEMBL3529338 0.93 HCRTR2 (0.48) HCRTR2HSD17B10HPGDHTTMAPK1
SCHEMBL20378329 0.86 HCRTR2 (0.46) HCRTR2HSD17B10HPGDHTTMAPK1
SCHEMBL20027750 0.81 ADORA3 (0.52) HCRTR2HSD17B10HPGDMAPK1ALDH1A1
SCHEMBL8614460 0.80 MAPT (0.36) HCRTR2HPGDMAPK1ALDH1A1KDM4E
SCHEMBL18114139 0.80 MAPT (0.40) HCRTR2HSD17B10HPGDMAPK1ALDH1A1
SCHEMBL26101348 0.78 TARBP2 (0.50) HCRTR2HSD17B10HPGDHTTFBP1
SCHEMBL3822457 0.77 HCRTR2 (0.34) HCRTR2HPGDALDH1A1TSHRMAPT
SCHEMBL3527027 0.76 MEN1 (0.40) HCRTR2HSD17B10HPGDHTTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2096111-A1 PYRAZOLES AND USE THEREOF AS DRUGS Japan Tobacco Inc. (JP) 2009-09-02 EP disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF JAPAN TOBACCO, INC. (JP) 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036450-A1 PYRAZOLE COMPOUNDS AND USE THEREOF PYGL, GYS2, G6PC1 HCRTR2 4733/4885HSD17B10 327/4885HPGD 675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.